Phenotypic Assays

Assays that quantify disease phenotype changes in cells require no a priori knowledge of disease mechanism of action. A good example of this is in the field of oncology, where uncontrolled cell proliferation is a hallmark of cancer and can be used as the basis for a phenotypic assay. Cytation and Lionheart can quantify many types of phenotype change, such as counting cells by either fluorescence or brightfield microscopy in the case of cell proliferation. Many other phenotypes can be quantified based on the use of specific fluorescent probes, such as those for oxidative stress, hypoxia, apoptosis, translocation, etc and the image analysis capabilities of Gen5 Image Prime that provide dual masking capabilities and sub-population analyses based on a wide range of calculated metrics.

 MDA-MB-231-cells-at-20x-0-Hours
MDA-MB-231-cells-at-20x-6-Hours
MDA-MB-231-cells-at-20x-24-Hours

Phase contrast monitoring of MDA-MB-231 cells undergoing oridonin-induced apoptosis at 0, 6 and 20 hrs.

 

Application Notes:

 

Visual Abstracts (.mp4):

BioTek’s Visual Abstracts are brief animated presentations describing the Augmented Microscopy workflow of a specific application.

link

We use cookies to provide visitors of our website the best possible experience. If you continue without changing your browser settings, we'll assume you are happy to receive all cookies on the BioTek website. To learn more how we use cookies or how to block cookies, please visit our cookie policy.